ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,174Medicare Part D Prescriptions Filled, Including Refills
$700K Total Retail Price of All Prescriptions
1,000 Patients Receiving at Least One Drug in Part D
30%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
MORPHINE SULFATE ER 879 221 S2
OXYCODONE HCL 798 189 S2
FENTANYL 590 237 S2
HYDROCODONE-ACETAMINOPHEN 577 225 S3
TRAMADOL HCL 368 90
OXYCODONE HCL-ACETAMINOPHEN 359 126 S2
GABAPENTIN 337 91
OXYCONTIN 254 32 S2
OXYCODONE-ACETAMINOPHEN 241 41 S2
METHADONE HCL 226 44 S2
TIZANIDINE HCL 210 45
OPANA ER 205 25 S2
BACLOFEN 178 23
LYRICA 130 48
MORPHINE SULFATE 130 20 S2
METHOCARBAMOL 124 0 R
ZONISAMIDE 108 0
CYMBALTA 104 33
CYCLOBENZAPRINE HCL 87 0 R
EXALGO 81 11 S2
ZOLPIDEM TARTRATE 75 21
NUCYNTA 66 0 S2
LIDOCAINE-PRILOCAINE 66 20
BUTRANS 60 27 S3
NUCYNTA ER 53 17 S2
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.